Chase AIPricingFAQs
Display currency
Loading news…

Glycomine

ActiveOperating status — whether the company still runs independently. “Closed” usually means it was acquired, merged, or shut down.🔥 LowHeat score — how much recent activity & attention the company has (web traffic, news, hiring).📈 Low growthGrowth score — momentum trend across web traffic, headcount and other growth signals.
San Carlos, California, United States Founded 2013 11-50 employees For Profit

Glycomine is an early-stage biotech working on replacement therapies for rare diseases.

Total Funding
Available in Pro
Last Funding
Available in Pro
Acquisitions
0
Monthly Visits
Available in Pro
Contacts
10

Company Details

Funding & Financials

Pro
Total funding
Funding rounds
Last funding
Last funding type
Last funding date
Funding status
Total equity funding
Revenue range

IPO & Stock

IPO status
Private
Valuation range
$100M to $500M

Web Traffic

Pro
Monthly visits
Global traffic rank
6-mo avg visits
Visit duration (s)
Pages / visit
Bounce rate
Rank change (mo)

Technology & IP

Active technologies
36
Active products
19
IT spend
$190K

Company Info

Founded
2013
Employees
11-50
Operating status
Active
Company type
For Profit
Org types
company
Founders
1
News articles
31
HQ
San Carlos, California, United States
Region
San Francisco Bay Area, Silicon Valley, West Coast
Diversity spotlight
Women Founded

Signals & Scores

Heat score
Low
Growth score
Low
Trend (7d)
-0.1
Trend (30d)
1.2
Trend (90d)
-2
Last leadership hire
Oct 12, 2023

Key People at Glycomine

Chief Medical Officer
Chief Executive Officer
Director of R&D, Biology
10
professional contacts at Glycomine
Contact execs at Glycomine

Explore 200,000+ acquisitions — free

Filter the full database across sectors, companies, dates, and deal sizes. No signup, no paywall.

Explore all acquisitions

Recent News related to Glycomine

Loading news…

FAQs about Glycomine

People who checked this page also checked these

Browse the full Acquirezy directory.
Glycomine - Company Profile, Full Acquisitions List, Funding and Investments